Protein neddylation and its alterations in human cancers for targeted therapy
L Zhou, W Zhang, Y Sun, L Jia - Cellular signalling, 2018 - Elsevier
Neddylation, a post-translational modification that conjugates an ubiquitin-like protein
NEDD8 to substrate proteins, is an important biochemical process that regulates protein …
NEDD8 to substrate proteins, is an important biochemical process that regulates protein …
E1 enzymes as therapeutic targets in cancer
SH Barghout, AD Schimmer - Pharmacological reviews, 2021 - ASPET
Post-translational modifications of cellular substrates with ubiquitin and ubiquitin-like
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …
proteins (UBLs), including ubiquitin, SUMOs, and neural precursor cell–expressed …
[HTML][HTML] Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
Q Feng, Y Liu, J Huang, K Chen, J Huang, K Xiao - Scientific reports, 2018 - nature.com
Iron oxide nanoparticles (IONPs) have been increasingly used in biomedical applications,
but the comprehensive understanding of their interactions with biological systems is …
but the comprehensive understanding of their interactions with biological systems is …
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
DJ Fu, T Wang - Journal of Hematology & Oncology, 2023 - Springer
NEDDylation, a post-translational modification through three-step enzymatic cascades,
plays crucial roles in the regulation of diverse biological processes. NEDD8-activating …
plays crucial roles in the regulation of diverse biological processes. NEDD8-activating …
The NEDD8-activating enzyme inhibitor MLN4924 reduces ischemic brain injury in mice
H Yu, H Luo, L Chang, S Wang… - Proceedings of the …, 2022 - National Acad Sciences
Blood–brain barrier (BBB) breakdown and inflammation occurring at the BBB have a key,
mainly a deleterious role in the pathophysiology of ischemic stroke. Neddylation is a …
mainly a deleterious role in the pathophysiology of ischemic stroke. Neddylation is a …
[HTML][HTML] Targeting cullin neddylation for cancer and fibrotic diseases
ZX He, W Yang, D Zengyangzong, G Gao, Q Zhang… - Theranostics, 2023 - ncbi.nlm.nih.gov
Protein neddylation is a post-translational modification, and its best recognized substrates
are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs) …
are cullin family proteins, which are the core component of Cullin-RING ligases (CRLs) …
[HTML][HTML] Major roles of the circadian clock in cancer
C Huang, C Zhang, Y Cao, J Li, F Bi - Cancer Biology & Medicine, 2023 - ncbi.nlm.nih.gov
Circadian rhythms are natural rhythms that widely exist in all creatures, and regulate the
processes and physiological functions of various biochemical reactions. The circadian clock …
processes and physiological functions of various biochemical reactions. The circadian clock …
Protein neddylation and its role in health and diseases
NEDD8 (Neural precursor cell expressed developmentally downregulated protein 8) is an
ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate …
ubiquitin-like protein that is covalently attached to a lysine residue of a protein substrate …
Cullin-RING E3 ubiquitin ligases: bridges to destruction
Ubiquitination is a highly conserved post-translational modification in eukaryotes, well
known for targeting proteins for degradation by the 26S proteasome. Proteins destined for …
known for targeting proteins for degradation by the 26S proteasome. Proteins destined for …
MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma
S Tong, Y Si, H Yu, L Zhang, P Xie, W Jiang - Scientific reports, 2017 - nature.com
Neddylation is a post-translational protein modification associated with cancer development.
MLN4924 is a neddylation inhibitor currently under investigation in multiple phase I studies …
MLN4924 is a neddylation inhibitor currently under investigation in multiple phase I studies …